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the nineteenth and twentieth centuries. For example, a review and clus-
ter analysis of post-combat syndromes from a random sample of more
than 1800 records in British veterans from the Boer War to the Gulf
War demonstrated the rise and fall of different chronic syndromes, in-
cluding disordered activity of the heart, non-ulcer dyspepsia, shell
shock and neurasthenia, as well as those of contemporary records of
GWI (Jones et al., 2002).
Complex, poorly understood conditions demand consideration
In this issue of EBioMedicine, Georgopoulos et al. report signiﬁcant
differences in the frequency of six HLA alleles in a sample of 66 US
Gulf War illness (GWI) veterans and 16 healthy veteran controls
(Georgopoulos et al., 2016). Their interpretation is that these alleles
conferred a protective effect, as evidenced by the negative association
between GWI symptom severity and allele counts, such that higher al-
lele counts were associated with lower symptom severity in the whole
sampled population.
GWI is a chronic multi-symptom illness reported by soldiers
returning from the Gulf War of 1990–1991. As many as one in four of
700,000 US soldiers reported such symptoms, which included cognitive
and mood disturbance, fatigue, musculoskeletal and other non-speciﬁc
complaints (Steele, 2000). It also affected other armies serving in that
war. For example, 17% of almost 3000 UK veterans reported having
GWI (Chalder et al., 2001).
The etiology of these chronic symptoms has been difﬁcult to
elucidate despite extensive, if retrospective, research and investment.
Suggested mechanisms have included multiple vaccinations, chemical
exposure in theater, the use of pyridostigmine bromide as a prophylac-
tic against nerve gas attacks and other exposures such as depleted
uranium used in weaponry. GWI has also been viewed as a chronic
medically unexplained illness comparable to chronic fatigue syndrome
(CFS) (Iversen et al., 2007). Indeed, the US Institute of Medicine uses
the term chronic multi-symptom illness rather than GWI in reference
to this topic. Immunological models of pathophysiology have been ex-
plored, particularly with respect to the impact of multiple vaccinations
in a stressful environment, and it is here that the reported ﬁnding may
add evidence if replicated. However, it is important to note that not all
forces carried out such extensive immunization programs, such as
Denmark, whose soldiers have similarly suffered illness following the
Gulf War. Furthermore, history shows that war makes soldiers ill, withom.2015.11.037.
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Biopsychosocial approaches are well established in optimizing treat-
ment of several chronic conditions, regardless of etiology — be it
heart disease, diabetes or CFS. In particular, cognitive behavioral
therapy (CBT) and a graded approach to increasing activity have
been found to improve outcomes in CFS. However, a randomized
controlled trial (RCT) of exactly this approach (CBT and graded exer-
cise) in GWI demonstrated only modest beneﬁt, in a sample of 1092
US GWI sufferers with 11% improving at 1 year with usual care, 18%
with CBT (OR= 1.7) and the exercise intervention having a minimal
impact (Donta et al., 2003). Differences between soldiers and the
general population these interventions were developed for (in base-
line activity levels for example), may have limited the effectiveness
of the intervention. Psychological or functional interventions for
chronic illness may have low acceptability amongst young ﬁt sol-
diers and their superiors. Clearly this leaves a need to explore other
treatments to beneﬁt ill veterans.
The plight of GWI sufferers, many of whom remain chronically
symptomatic, has driven funding and research into approaches to better
support soldiers following deployment. In the US for example, a
resilience program (‘Battlemind’) has been developed which appeared
to reduce the burden of stress related and post-traumatic symptoms.
However, a UK RCT failed to demonstrate its effectiveness in a British
Army population (Mulligan et al., 2012). Meanwhile, active service
continues to induce a somewhat lower but still signiﬁcant incidence of
similar symptoms following deployment in Iraq and Afghanistan.
There remains scope for immune and genetic hypotheses to inform
our understanding of GWI and similar syndromes. One hypothesis has
been that a stress-induced modulation of circulating pro-inﬂammatory
factors may have primed soldiers to have an exaggerated response to in-
sults, be they chemical exposure, vaccination post-deployment or other
medication, thus precipitating GWI. Recent reports include that of great-
er cytokine variability in veterans with GWI compared to controls
(Parkitny et al., 2015), and of a mousemodel of increased corticosterone
(consistentwith a physiological stress state) priming a pro-inﬂammatoryC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in GWI (O'Callaghan et al., 2015). Such ﬁndings are not speciﬁc to GWI,
but if replicated they do at least offer the possibility of new hope and
treatments. We note that recruitment is underway in Minnesota for
a trial of prednisone, a steroid with anti-inﬂammatory properties,
in GWI. To date, large-scale replication of immunological mechanisms
in the etiology of GWI has remained elusive and the heterogeneity of
exposures (e.g. vaccinations) across different armies remains a challenge
to rigorously testing this hypothesis.
The ﬁndings reported by Georgopoulos et al. suggest that a genetic
immunological factor may have played a protective role against GWI
in soldiers. Scientiﬁc caution demands, as the authors suggest, replica-
tion in other and much larger samples. One cannot help exercise a de-
gree of healthy skepticism in a ﬁeld so extensively studied with such
little obvious advance in treatment in the past two decades, but any
potentially robust means of a step forward can only be welcomed.
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